|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Early fluid resuscitation improves outcomes in severely burned children显示文摘 | Robert E. Barrow Marc G. Jeschke David N. Herndon | 2000 | Resuscitation2000，，2： | 2 |
| 2 | Severe Injury Is Associated With Insulin Resistance, Endoplasmic Reticulum Stress Response, and Unfolded Protein Response显示文摘 | Marc G. Jeschke Celeste C. Finnerty David N. Herndon Juquan Song Darren Boehning Ronald G. Tompkins Henry V. Baker Gerd G. Gauglitz | 2012 | Annals of Surgery2012，，2： | 1 |
| 3 | Bacterial respiratory tract infections are promoted by systemic hyperglycemia after severe burn injury in pediatric patients显示文摘 | Robert Kraft David N. Herndon Ronald P. Mlcak Celeste C. Finnerty Robert A. Cox Felicia N. Williams Marc G. Jeschke | 2014 | Burns2014，，3： | 1 |
| 4 | Development of New Reconstructive Techniques: Use of Integra in Combination with Fibrin Glue and Negative-Pressure Therapy for Reconstruction of Acute and Chronic Wounds显示文摘 | Marc G. Jeschke Christoph Rose Peter Angele Bernd Füchtmeier Michael N. Nerlich Ulrich Bolder | 2004 | Plastic and Reconstructive Surgery2004，，： | 1 |
| 5 | The factor age and the recovery of severely burned children 显示文摘 | RENE PRZKORA DAVID N HERNDON MARC G JESCHKE | 2008 | BURNS2008，34，1： | 1 |
| 6 | Morbidity and Survival Probability in Burn Patients in Modern Burn Care*显示文摘 | Marc G. Jeschke Ruxandra Pinto Robert Kraft Avery B. Nathens Celeste C. Finnerty Richard L. Gamelli Nicole S. Gibran Matthew B. Klein Brett D. Arnoldo Ronald G. Tompkins David N. Herndon | 2015 | Critical Care Medicine2015，，4： | 1 |
| 7 | Insulin Attenuates Apoptosis and Exerts Anti-Inflammatory Effects in Endotoxemic Human Macrophages显示文摘 | Mareike Leffler Thomas Hrach Michael Stuerzl Raymund E. Horch David N. Herndon Marc G. Jeschke | 2007 | Journal of Surgical Research2007，，2： | 1 |
| 8 | The effect of short-term growth hormone treatment on growth and energy expenditure in burned children显示文摘 | J.F Aili Low Robert E Barrow Bettina Mittendorfer Marc G Jeschke David L Chinkes David N Herndon | 2001 | Burns2001，，5： | 1 |
| 9 | Intensive insulin treatment increases donor site wound protein synthesis in burn patients显示文摘 | Demidmaa Tuvdendorj Xiao-Jun Zhang David L. Chinkes Asle Aarsland Gabriela A. Kulp Marc G. Jeschke David N. Herndon | 2011 | Surgery2011，，4： | 1 |
| 10 | Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix显示文摘 | Jurgen K Marc G Jeschke P | 2004 | Cell and Tissue Banking2004，2，5： | 1 |
| 11 | Modulation of the Hypermetabolic Response to Trauma: Temperature, Nutrition, and Drugs显示文摘 | Felicia N. Williams Marc G. Jeschke David L. Chinkes Oscar E. Suman Ludwik K. Branski David N. Herndon | 2009 | Journal of the American College of Surgeons2009，，4： | 1 |
| 12 | Occurrence of Multiorgan Dysfunction in Pediatric Burn Patients: Incidence and Clinical Outcome显示文摘 | Robert Kraft David N. Herndon Celeste C. Finnerty Shahriar Shahrokhi Marc G. Jeschke | 2014 | Annals of Surgery2014，，2： | 1 |
| 13 | Cytokine expression profile over time in burned mice显示文摘 | Celeste C. Finnerty Rene Przkora David N. Herndon Marc G. Jeschke | 2008 | Cytokine2008，，1： | 1 |
| 14 | Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances显示文摘Hematopoietic stem cells(HSCs) have become the most extensively studied stem cells and HSC-based cellular therapy is promising for hematopoietic cancers and hereditary blood disorders. Successful treatment of patients with HSC cells depends on sufficient number of highly purified HSCs and progenitor cells. However, stem cells are a very rare population no matter where they come from. Thus, ex vivo amplification of these HSCs is essential. The heavy demands from more and more patients for HSCs also require industrial-scale expansion of HSCs with lower production cost and higher efficiency. Two main ways to reach that goal:(1) to find clinically applicable, simple and efficient methods(or reagents) to enrich HSCs;(2) to find new developmental regulators and chemical compounds in order to replace the currently used cytokine cocktails for HSCsamplification. In this Editorial review, we would like to introduce the current status of ex vivo expansion of HSCs, particularly focusing on enrichment and culture supplements. | Katsuhiro Kita Fangming Xiu Marc G Jeschke | 2014 | World Journal of Hematology2014，3，2： | 0 |
| 15 | Ventilation practices in burn patients—an international prospective observational cohort study显示文摘Background:It is unknown whether lung-protective ventilation is applied in burn patients and whether they benefit from it.This study aimed to determine ventilation practices in burn intensive care units(ICUs)and investigate the association between lung-protective ventilation and the number of ventilator-free days and alive at day 28(VFD-28).Methods:This is an international prospective observational cohort study including adult burn patients requiring mechanical ventilation.Low tidal volume(V_(T))was defined as V_(T)≤8 mL/kg predicted body weight(PBW).Levels of positive end-expiratory pressure(PEEP)and maximum airway pressures were collected.The association between V_(T) and VFD-28 was analyzed using a competing risk model.Ventilation settings were presented for all patients,focusing on the first day of ventilation.We also compared ventilation settings between patients with and without inhalation trauma.Results:A total of 160 patients from 28 ICUs in 16 countries were included.Low V_(T) was used in 74%of patients,median V_(T) size was 7.3[interquartile range(IQR)6.2–8.3]mL/kg PBW and did not differ between patients with and without inhalation trauma(p=0.58).Median VFD-28 was 17(IQR 0–26),without a difference between ventilation with low or high V_(T)(p=0.98).All patients were ventilated with PEEP levels≥5 cmH_(2)O;80%of patients had maximum airway pressures<30 cmH_(2)O.Conclusion:In this international cohort study we found that lung-protective ventilation is used in the majority of burn patients,irrespective of the presence of inhalation trauma.Use of low V_(T) was not associated with a reduction in VFD-28.Trial registration:Clinicaltrials.gov NCT02312869.Date of registration:9 December 2014. | Gerie J.Glas Janneke Horn Markus W.Hollmann Benedikt Preckel Kirsten Colpaert Manu Malbrain Ary Serpa Neto Karim Asehnoune Marcello Gamma de Abreu Ignacio Martin-Loeches Paolo Pelosi Folke Sjoerg Jan M.Binnekade Berry Cleffken Nicole P.Juffermans Paul Knape Bert G.Loef David P.Mackie Perenlei Enkhbaatar Nadia Depetris Anders Perner Eva Herrero Lucia Cachafeiro Marc Jeschke Jeffrey Lipman Matthieu Legrand Johannes Horter Athina Lavrentieva Alex Kazemi Anne Berit Guttormsen Frederik Huss Mark Kol Helen Wong Therese Starr Luc De Crop Wilson de Oliveira Filho Joa Manoel Silva Junior Cintia M.C.Grion Marjorie Burnett Frederik Mondrup Francois Ravat Mathieu Fontaine Renan Le Floch Mathieu Jeanne Morgane Bacus Maite Chaussard Marcus Lehnhardt Bassem Daniel Mikhail Jochen Gille Aidan Sharkey Nicole Trommel Auke C.Reidinga Nadine Vieleers Anna Tilsley Henning Onarheim Maria Teresa Bouza Alexander Agrifoglio Filip Fredén Tina Palmieri Lynda E.Painting Marcus J.Schultz LAMiNAR investigators | 2021 | Burns & Trauma2021，9，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员